z-logo
open-access-imgOpen Access
Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?
Author(s) -
Verbeke Frederick,
De Spiegeleer Bart
Publication year - 2021
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1002/ueg2.12066
Subject(s) - directive , medicine , european union , transplantation , good manufacturing practice , fecal bacteriotherapy , personalized medicine , business , microbiology and biotechnology , bioinformatics , international trade , regulatory affairs , surgery , biology , clostridium difficile , antibiotics , computer science , programming language

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here